Polyaza Iridium OLED Emitters for Saturated Color and Efficient Emission

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing organic light-emitting diodes (OLEDs) face challenges in achieving saturated colors and efficient light emission, particularly in full-color displays, due to limitations in phosphorescent emissive molecules.

Innovation Solution

The use of transition metal compounds with new polyaza-substituted ligands, specifically compounds of Formula Ir(LA)x(LC)y, where ligand LA and LC form a 5-membered chelate ring, to enhance the performance of OLED devices.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If conventional phosphorescent emissive molecules are used in OLEDs, then device fabrication is simplified, but achieving saturated colors and efficient light emission is difficult

Engineering Contradiction:
Improvelight emission efficiencyVSAvoidcolor saturation
Core Design Contradiction:
Illumination intensityVSReliability

Solution Approach 1:

The patent modifies the molecular structure of phosphorescent emissive molecules by introducing polyaza-substituted ligands with specific coordination modes to the iridium center. This changes the electronic and photophysical parameters of the emitter, resulting in enhanced phosphorescence quantum yields and improved color saturation across red, green, and blue emission wavelengths.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention employs composite ligand systems comprising polyaza-substituted ligands coordinated to iridium metal centers. These composite materials combine the advantages of strong spin-orbit coupling from the heavy metal with the tunable photophysical properties of the organic ligands, achieving both high efficiency and saturated colors.

Inventive Principle:
Principle #40Composite materials

2Productivity

If new polyaza-substituted ligands are used to improve light emission, then device performance improves, but device complexity increases

Engineering Contradiction:
Improvedevice performanceVSAvoidmolecular structure complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The complex ligand structure is divided into modular components: polyaza-substituted core structures with specific coordinating atoms positioned to form stable chelate rings with the iridium center. This segmentation allows systematic optimization of different regions of the molecule for specific functions (emission color, stability, efficiency) independently.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces specific functional groups and substituent patterns at localized positions on the ligand framework. These local modifications tune the electronic properties and HOMO-LUMO energy levels to achieve desired emission characteristics without requiring complete redesign of the entire molecular structure.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Improves the device performance of OLEDs by enhancing light emission and color saturation, making them suitable for applications such as full-color displays.

Implementation Method 1

One application for phosphorescent emissive molecules is a full color display

Methodology Applied
Scientific EffectPhosphorescence: Phosphorescence

Implementation Method 2

OLEDs make use of thin organic films that emit light when voltage is applied across the device

Methodology Applied
Scientific EffectElectroluminescence: Electroluminescence

Data Source

PatentUS12384809B2Organic electroluminescent materials and devices
Publication Date: 2025.08.12 UNIVERSAL DISPLAY CORP
  • US12384809B2 patent drawing
  • US12384809B2 patent drawing
  • US12384809B2 patent drawing

AI summary

Provided are compounds of Formula Ir(LA)x(LC)y wherein:ligand LA has Formula I′ and ligand LC has Formula II′